Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinzaparin vs Enoxaparin for Thromboprophylaxis in Bariatric Surgery
NCT07559643Not yet recruiting
- Sponsor
- University College Dublin
- Start
- Aug 2026
- Primary completion
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of tinzaparin in venous thromboembolism (VTE) (2 arms), sponsored by University College Dublin. Primary endpoint: Proportion of participants achieving prophylactic anti-Xa levels. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
tinzaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT07559643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07559643.